OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 551 - 560 of 764 studies

United Kingdom Register of Stored Ovarian and Testicular Tissue (UKSTORE)

A Non-interventional, Epidemiologic Study of XLMTM and Clinical Expression in the Liver

Real-World Effectiveness of Belumosudil for the Treatment of Chronic Graft vs. Host Disease: A Non-interventional Retrospective Cohort Study Using Patient Medical Records (ROCKreal2)

Cancer and neoplasms

A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF DIVARASIB AND PEMBROLIZUMAB VERSUS PEMBROLIZUMAB AND PEMETREXED AND CARBOPLATIN OR CISPLATIN IN PATIENTS WITH PREVIOUSLY UNTREATED, KRAS G12C-MUTATED, ADVANCED OR METASTATIC NON-SQUAMOUS NON−SMALL CELL LUNG CANCER (KRASCENDO-2)

NeoRet: Creating a Retinal Growth Chart for Early Life (NeoRet)

Inflammatory and immune system

A randomized, double-blind, Phase 3 study to evaluate the efficacy and safety of rilzabrutinib (SAR444671) compared to placebo in adult participants with active IgG4-related disease (EFC17359 (RILIEF))

Reproductive health and childbirth

A Phase 2, randomized, double-blind, placebo-controlled trial to investigate the efficacy and safety of 2 doses of vipoglanstat in patients with moderate to severe endometriosis-related pain – the NOVA trial (The NOVA trial)

Cancer and neoplasms

A Phase 3 Randomized, Open-Label, Multicenter Study of Sonrotoclax Plus Anti-CD20 Antibody Therapies Versus Venetoclax Plus Rituximab in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Understanding adherence to weekly growth hormone treatment: A mixed-methods observational longitudinal study.

Neurological

A Phase 2, Double-Blind Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Apitegromab in Subjects <2 Years Old With Spinal Muscular Atrophy (SMA) (OPAL)